刚上市的英硅智能,凭什么拿到施维雅8.88亿美元订单?AI制药正在重写游戏规则

MedTrend医趋势
Jan 06

1月5日,AI驱动药物发现公司英硅智能(Insilico Medicine)宣布,与施维雅(Servier)达成一项多年期研发合作协议。双方将构建战略联盟,依托英硅智能自主研发的Pharma.AI人工智能平台,针对肿瘤领域的难成药靶点,开展全新疗法的发现与开发工作。根据协议条款,英硅智能将获得最高3200万美元的预付款和近期研发付款,总金额约8.88亿美元,并将主导基于人工智能的药物发现工作,研发...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10